Last reviewed · How we verify
NCT01836744
Survival Rate of Dental Implants Placed in Sinus Lift Performed With Two Different Grafts
Phase 4 trial testing Survival rate dental implant (OsseoSpeed™) in Dental Implant Survival Rate in 12 participants. Completed in 30 July 2023.
20 June 2017
Quick facts
| Lead sponsor | Grupo de Investigação: Cirurgia Oral, Peridontologia, Implantologia |
|---|---|
| Phase | Phase 4 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 12 |
| Start date | 18 March 2013 |
| Primary completion | 20 June 2017 |
| Estimated completion | 30 July 2023 |
| Sites | 1 location across Portugal |
Drugs / interventions tested
- Survival rate dental implant (OsseoSpeed™)
Conditions studied
- Dental Implant Survival Rate — all drugs for Dental Implant Survival Rate →
Sponsor
Grupo de Investigação: Cirurgia Oral, Peridontologia, Implantologia
Who can join
18 and older, any sex, with Dental Implant Survival Rate. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Previous in a randomized way, it will be performance 12 bilateral sinus lift with autologous bone in one side and the in other with xenograft material. After 6 mouths we will place 1 to 3 implants in each side and analyse the survival rate and possibles differences related to; prosthesis failure; biological and prosthetic complications; peri-implant marginal bone level changes.
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
Advantages of Porcine Xenograft over Autograft in Sinus Lift: A Randomised Clinical Trial.
Correia F, Pozza DH, Gouveia S, Felino AC, et al · · 2021 · cited 20× · PMID 34205826 · DOI 10.3390/ma14123439 -
A Randomized Clinical Trial Comparing Implants Placed in Two Different Biomaterials Used for Maxillary Sinus Augmentation.
Correia F, Gouveia SA, Pozza DH, Felino AC, et al · · 2023 · cited 7× · PMID 36770223 · DOI 10.3390/ma16031220 -
Maxillary Sinus Augmentation with Xenogenic Collagen-Retained Heterologous Cortico-Cancellous Bone: A 3-Year Follow-Up Randomized Controlled Trial.
Correia F, Gouveia S, Felino AC, Faria-Almeida R, et al · · 2024 · cited 5× · PMID 38392237 · DOI 10.3390/dj12020033
Verify or expand the search:
- PubMed search for NCT01836744
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT01836744 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Grupo de Investigação: Cirurgia Oral, Peridontologia, Implantologia
- Last refreshed: 13 September 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01836744.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing